Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Chengbo
JCES 01.11 a Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients With IIIB/IV NSCLC in Northern China
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients With Advanced NSCLC Receiving EGFR-TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients With EGFR Mutations: A Real World Assessment
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA03 Afatinib Followed by Osimertinib in Real-World Patients With EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real‐world Data on EGFR/ALK Gene Status and First‐line Targeted Therapy Rate in Newly Diagnosed Advanced Non‐small Cell Lung Cancer Patients in Northern China: A Prospective Observational Study
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Retraction Note To: Neutropenia and Invasive Fungal Infection in Patients With Hematological Malignancies Treated With Chemotherapy: A Multicenter, Prospective, Non-Interventional Study in China
Tumor Biology
Medicine
Cancer Research
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real-World, Non-Interventional, Observational Study of Hydroxyzine Hydrochloride in Chronic Pruritus: A Prospective, Non-Comparative Study
Dermatology and Therapy
Dermatology
PEARL: A Non-Interventional Study of Real-World Alirocumab Use in German Clinical Practice
Drugs - Real World Outcomes
Pharmacology
